UnitedHealth Group Incorporated (UNH) Shares Sold by Hays Advisory LLC
Hays Advisory LLC cut its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 10.9% in the second quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 23,110 shares of the healthcare conglomerate’s stock after selling 2,833 shares during the quarter. UnitedHealth Group accounts for about 1.0% of Hays Advisory LLC’s investment portfolio, making the stock its 27th largest holding. Hays Advisory LLC’s holdings in UnitedHealth Group were worth $4,285,000 as of its most recent filing with the Securities & Exchange Commission.
Several other hedge funds also recently made changes to their positions in UNH. Waldron LP grew its stake in shares of UnitedHealth Group by 153.1% in the first quarter. Waldron LP now owns 5,765 shares of the healthcare conglomerate’s stock worth $944,000 after acquiring an additional 3,487 shares during the period. AMI Investment Management Inc. grew its stake in shares of UnitedHealth Group by 464.5% in the first quarter. AMI Investment Management Inc. now owns 91,445 shares of the healthcare conglomerate’s stock worth $2,252,000 after acquiring an additional 75,245 shares during the period. NBT Bank N A NY grew its stake in shares of UnitedHealth Group by 2.0% in the first quarter. NBT Bank N A NY now owns 26,861 shares of the healthcare conglomerate’s stock worth $4,405,000 after acquiring an additional 537 shares during the period. Howard Hughes Medical Institute bought a new stake in shares of UnitedHealth Group in the first quarter worth approximately $589,000. Finally, Glen Harbor Capital Management LLC grew its stake in shares of UnitedHealth Group by 256.0% in the first quarter. Glen Harbor Capital Management LLC now owns 116,240 shares of the healthcare conglomerate’s stock worth $19,064,000 after acquiring an additional 83,584 shares during the period. Hedge funds and other institutional investors own 86.19% of the company’s stock.
A number of research firms recently issued reports on UNH. ValuEngine raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating in a report on Friday, September 1st. Cantor Fitzgerald reissued a “buy” rating on shares of UnitedHealth Group in a report on Tuesday, August 29th. Zacks Investment Research raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $219.00 price objective on the stock in a report on Thursday. UBS AG reissued an “overweight” rating on shares of UnitedHealth Group in a report on Thursday, August 24th. Finally, Morgan Stanley raised their price objective on shares of UnitedHealth Group from $210.00 to $215.00 and gave the stock an “overweight” rating in a report on Thursday, August 17th. One analyst has rated the stock with a hold rating and twenty-five have given a buy rating to the stock. The stock presently has a consensus rating of “Buy” and a consensus target price of $203.59.
In other news, Director William C. Ballard, Jr. sold 5,000 shares of the stock in a transaction that occurred on Thursday, August 3rd. The stock was sold at an average price of $193.98, for a total transaction of $969,900.00. Following the transaction, the director now owns 76,058 shares in the company, valued at approximately $14,753,730.84. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Also, Director Richard T. Burke sold 15,000 shares of the stock in a transaction that occurred on Monday, August 21st. The shares were sold at an average price of $191.71, for a total value of $2,875,650.00. Following the transaction, the director now owns 1,818,898 shares in the company, valued at approximately $348,700,935.58. The disclosure for this sale can be found here. Insiders have sold a total of 76,174 shares of company stock worth $14,981,909 in the last quarter. Insiders own 0.89% of the company’s stock.
UnitedHealth Group Incorporated (UNH) traded down 1.12% during trading on Friday, hitting $193.03. 5,660,220 shares of the stock traded hands. The stock has a market cap of $186.63 billion, a P/E ratio of 23.19 and a beta of 0.63. The stock has a 50 day moving average price of $195.56 and a 200-day moving average price of $181.26. UnitedHealth Group Incorporated has a 52-week low of $133.03 and a 52-week high of $200.76.
UnitedHealth Group (NYSE:UNH) last announced its earnings results on Tuesday, July 18th. The healthcare conglomerate reported $2.46 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.38 by $0.08. UnitedHealth Group had a return on equity of 21.52% and a net margin of 4.32%. The firm had revenue of $50.05 billion for the quarter, compared to analyst estimates of $49.97 billion. During the same quarter last year, the firm posted $1.96 EPS. The business’s revenue was up 7.7% on a year-over-year basis. On average, analysts anticipate that UnitedHealth Group Incorporated will post $9.87 EPS for the current fiscal year.
The firm also recently announced a quarterly dividend, which was paid on Tuesday, September 19th. Stockholders of record on Friday, September 8th were given a dividend of $0.75 per share. The ex-dividend date of this dividend was Thursday, September 7th. This represents a $3.00 dividend on an annualized basis and a dividend yield of 1.55%. UnitedHealth Group’s dividend payout ratio (DPR) is 35.13%.
UnitedHealth Group Company Profile
UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH).
Receive News & Ratings for UnitedHealth Group Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Incorporated and related companies with Analyst Ratings Network's FREE daily email newsletter.